{
  "main_header": {
    "sid": 10039076,
    "name": "Sunrest Lifescie",
    "stock_name": "Sunrest Lifescie",
    "full_name": "Sunrest Lifescience Ltd",
    "name_url": "stocks-analysis/sunrest-lifescie",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "42.05",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "42.05",
    "mcapval": "18.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SUNREST",
    "ind_name": "Healthcare Services",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE0PLZ01012",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 3200,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sunrest-lifescie-10039076-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Sunrest Lifescie overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sunrest-lifescie-overvalued-or-undervalued-3709955",
        "imagepath": "",
        "date": "2025-11-18 08:25:31",
        "description": "As of 17 November 2025, Sunrest Lifescie has moved from a fair to an attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 9.87, an EV to EBITDA of 8.54, and a PEG ratio of 0.01, indicating strong potential for growth relative to its price.\n\nIn comparison to its peers, Sunrest Lifescie stands out with a significantly lower PE ratio than Elitecon International, which is very expensive at 294.38, and MMTC, which has a PE of 139.7. Additionally, PTC India, categorized as very attractive, has a PE of 7.56, further emphasizing Sunrest Lifescie's favorable valuation position. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -10.68% versus the Sensex's 10.02%, the underlying financial metrics suggest that Sunrest Lifescie presents a compelling investment opportunity...."
      },
      {
        "title": "How has been the historical performance of Sunrest Lifescie?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sunrest-lifescie-3699813",
        "imagepath": "",
        "date": "2025-11-13 23:51:33",
        "description": "Answer:\nThe historical performance of Sunrest Lifescie shows a consolidated net profit of 2.01 crore for the year ending March 2025, with net sales amounting to 33.41 crore. The total operating income for the same period was also 33.41 crore, while total expenditure, excluding depreciation, was 30.39 crore, resulting in an operating profit (PBDIT) of 3.02 crore. The profit before tax stood at 2.62 crore, leading to a profit after tax of 2.01 crore after accounting for tax expenses of 0.61 crore. The earnings per share (EPS) were reported at 4.69, with a PAT margin of 6.02%. \n\nIn terms of balance sheet metrics, the total assets of Sunrest Lifescie reached 35.13 crore, with total liabilities also at 35.13 crore, indicating a balanced position. The company’s shareholder's funds increased to 16.19 crore, up from 14.19 crore in the previous year. Long-term borrowings rose to 4.08 crore, while total debt remained..."
      },
      {
        "title": "Why is Sunrest Lifescie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunrest-lifescie-fallingrising-3645224",
        "imagepath": "",
        "date": "2025-10-25 00:14:03",
        "description": "As of 24-Oct, Sunrest Lifescience Ltd is experiencing a decline in its stock price, currently at Rs 42.00, which reflects a decrease of Rs 2.5 or 5.62%. The stock has underperformed significantly, with a 1-week return of -7.69% and a year-to-date decline of -18.45%. It is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 4.4% away from Rs 40.15. However, there has been a notable increase in investor participation, with delivery volume rising by 250% against the 5-day average, suggesting some interest despite the overall negative performance.\n\nIn the broader market context, the Sensex has shown a positive return of +0.33% over the past week, contrasting sharply with Sunrest Lifescience's decline. This indicates that the stock is not only underperforming relative to the marke..."
      },
      {
        "title": "Why is Sunrest Lifescie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunrest-lifescie-fallingrising-3611447",
        "imagepath": "",
        "date": "2025-10-10 23:40:00",
        "description": "As of 10-Oct, Sunrest Lifescience Ltd is experiencing a price increase, currently at 45.50, reflecting a rise of 2.5 or 5.81%. Despite this positive movement today, the stock has underperformed in the longer term, with a 1-week decline of 3.60%, a 1-month drop of 7.33%, and a year-to-date decrease of 11.65%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a significant decline in investor participation, with delivery volume dropping by 92.54% compared to the 5-day average, suggesting reduced interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Sunrest Lifescience's short-term performance has been unfavorable compared to the benchmark, as the Sensex has..."
      },
      {
        "title": "Why is Sunrest Lifescie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunrest-lifescie-fallingrising-3605395",
        "imagepath": "",
        "date": "2025-10-09 00:24:13",
        "description": "As of 08-Oct, Sunrest Lifescience Ltd is currently priced at 43.40, showing no change (0.00%). The stock has underperformed significantly over various periods, with a 1-week decline of 8.05%, a 1-month drop of 11.43%, and a year-to-date decrease of 15.73%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 86.11% compared to the 5-day average, which suggests reduced interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, the stock's performance has been poor relative to the benchmark, the Sensex, which has gained 0.84% over the past week while Sunrest Lifescience Ltd has lost 8.05%. This ..."
      },
      {
        "title": "Why is Sunrest Lifescie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunrest-lifescie-fallingrising-3575670",
        "imagepath": "",
        "date": "2025-09-26 23:35:46",
        "description": "As of 26-Sep, Sunrest Lifescience Ltd is experiencing a price increase, currently at 47.20, reflecting a change of 3.2 or 7.27% upward. The stock has outperformed its sector today by 8.82%, and there has been a significant rise in investor participation, with delivery volume increasing by 1733.33% compared to the 5-day average. However, while the stock has shown a positive movement today, it has underperformed over the longer term, with a year-to-date decline of 8.35% and a one-year drop of 23.81%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, the stock's short-term performance over the past week shows a gain of 6.07%, contrasting sharply with the benchmark Sensex, which has declined by 2.65% during the same period. This indicates that Sunrest Lifescience Ltd is currently gaining..."
      },
      {
        "title": "Is Sunrest Lifescie overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sunrest-lifescie-overvalued-or-undervalued-3569197",
        "imagepath": "",
        "date": "2025-09-25 08:03:21",
        "description": "As of 24 September 2025, the valuation grade for Sunrest Lifescie has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a PE ratio of 9.44, an EV to EBITDA of 8.26, and a PEG ratio of 0.01. These ratios suggest that while the company is not undervalued, it also does not exhibit the characteristics of being overvalued.\n\nIn comparison to its peers, Sunrest Lifescie's valuation is significantly lower than that of Elitecon International, which has a PE ratio of 493.62, and Lloyds Enterprises, with a PE of 29.64. However, it is more favorable than PTC India, which has a PE of 8.19, indicating that Sunrest is positioned reasonably within its competitive landscape. Notably, the stock has underperformed against the Sensex, with a year-to-date return of -14.56% compared to the Sensex's positive return of 5.97%, reinforcing the notion of a fair valuation amidst ..."
      },
      {
        "title": "Why is Sunrest Lifescie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunrest-lifescie-fallingrising-3568723",
        "imagepath": "",
        "date": "2025-09-24 23:43:39",
        "description": "As of 24-Sep, Sunrest Lifescience Ltd is currently priced at 44.00, with no change in price (0.00%, flat). The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in its price performance. Despite this, there has been a significant increase in investor participation, with delivery volume rising by 1733.33% against the 5-day average, suggesting heightened interest in the stock. Over the past month, the stock has experienced a decline of 14.48%, while its year-to-date performance shows a drop of 14.56%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Sunrest Lifescience's short-term performance has been relatively better than the benchmark Sensex, which has declined by 1.08% over the past week compared to the ..."
      },
      {
        "title": "Why is Sunrest Lifescie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunrest-lifescie-fallingrising-3562691",
        "imagepath": "",
        "date": "2025-09-23 23:52:55",
        "description": "As of 23-Sep, Sunrest Lifescience Ltd is experiencing a decline in its stock price, currently at Rs. 44.00, which reflects a decrease of Rs. 4.2 or 8.71%. The stock has hit a new 52-week low today and has underperformed its sector by 7.13%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 0.68%, and in the last month, it has seen a significant drop of 14.48%. Year-to-date, the stock is down 14.56%, and over the past year, it has fallen by 26.30%. Notably, there has been a rise in investor participation, with delivery volume increasing by 66.67% against the 5-day average, indicating some interest despite the overall decline.\n\nIn the broader market context, the Sensex has shown a slight decline of 0.28% over the past week, which is less than the stock's performance. While the benchmark has gained 1.20% in the last..."
      }
    ],
    "total": 86,
    "sid": "10039076",
    "stock_news_url": "https://www.marketsmojo.com/news/sunrest-lifescience-10039076"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Sunrest Lifescie overvalued or undervalued?

2025-11-18 08:25:31

As of 17 November 2025, Sunrest Lifescie has moved from a fair to an attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 9.87, an EV to EBITDA of 8.54, and a PEG ratio of 0.01, indicating strong potential for growth relative to its price. In comparison to its peers, Sunrest Lifescie stands out with a significantly lower PE ratio than Elitecon International, which is very expensive at 294.38, and MMTC, which has a PE of 139.7. Additionally, PTC India, categorized as very attractive, has a PE of 7.56, further emphasizing Sunrest Lifescie's favorable valuation position. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -10.68% versus the Sensex's 10.02%, the underlying financial metrics suggest that Sunrest Lifescie presents a compelling investment opportunity....

Read More

How has been the historical performance of Sunrest Lifescie?

2025-11-13 23:51:33

Answer: The historical performance of Sunrest Lifescie shows a consolidated net profit of 2.01 crore for the year ending March 2025, with net sales amounting to 33.41 crore. The total operating income for the same period was also 33.41 crore, while total expenditure, excluding depreciation, was 30.39 crore, resulting in an operating profit (PBDIT) of 3.02 crore. The profit before tax stood at 2.62 crore, leading to a profit after tax of 2.01 crore after accounting for tax expenses of 0.61 crore. The earnings per share (EPS) were reported at 4.69, with a PAT margin of 6.02%. In terms of balance sheet metrics, the total assets of Sunrest Lifescie reached 35.13 crore, with total liabilities also at 35.13 crore, indicating a balanced position. The company’s shareholder's funds increased to 16.19 crore, up from 14.19 crore in the previous year. Long-term borrowings rose to 4.08 crore, while total debt remained...

Read More

Why is Sunrest Lifescie falling/rising?

2025-10-25 00:14:03

As of 24-Oct, Sunrest Lifescience Ltd is experiencing a decline in its stock price, currently at Rs 42.00, which reflects a decrease of Rs 2.5 or 5.62%. The stock has underperformed significantly, with a 1-week return of -7.69% and a year-to-date decline of -18.45%. It is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 4.4% away from Rs 40.15. However, there has been a notable increase in investor participation, with delivery volume rising by 250% against the 5-day average, suggesting some interest despite the overall negative performance. In the broader market context, the Sensex has shown a positive return of +0.33% over the past week, contrasting sharply with Sunrest Lifescience's decline. This indicates that the stock is not only underperforming relative to the marke...

Read More

Why is Sunrest Lifescie falling/rising?

2025-10-10 23:40:00

As of 10-Oct, Sunrest Lifescience Ltd is experiencing a price increase, currently at 45.50, reflecting a rise of 2.5 or 5.81%. Despite this positive movement today, the stock has underperformed in the longer term, with a 1-week decline of 3.60%, a 1-month drop of 7.33%, and a year-to-date decrease of 11.65%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a significant decline in investor participation, with delivery volume dropping by 92.54% compared to the 5-day average, suggesting reduced interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Sunrest Lifescience's short-term performance has been unfavorable compared to the benchmark, as the Sensex has...

Read More

Why is Sunrest Lifescie falling/rising?

2025-10-09 00:24:13

As of 08-Oct, Sunrest Lifescience Ltd is currently priced at 43.40, showing no change (0.00%). The stock has underperformed significantly over various periods, with a 1-week decline of 8.05%, a 1-month drop of 11.43%, and a year-to-date decrease of 15.73%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a notable decline in investor participation, with delivery volume falling by 86.11% compared to the 5-day average, which suggests reduced interest in the stock. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, the stock's performance has been poor relative to the benchmark, the Sensex, which has gained 0.84% over the past week while Sunrest Lifescience Ltd has lost 8.05%. This ...

Read More

Why is Sunrest Lifescie falling/rising?

2025-09-26 23:35:46

As of 26-Sep, Sunrest Lifescience Ltd is experiencing a price increase, currently at 47.20, reflecting a change of 3.2 or 7.27% upward. The stock has outperformed its sector today by 8.82%, and there has been a significant rise in investor participation, with delivery volume increasing by 1733.33% compared to the 5-day average. However, while the stock has shown a positive movement today, it has underperformed over the longer term, with a year-to-date decline of 8.35% and a one-year drop of 23.81%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, the stock's short-term performance over the past week shows a gain of 6.07%, contrasting sharply with the benchmark Sensex, which has declined by 2.65% during the same period. This indicates that Sunrest Lifescience Ltd is currently gaining...

Read More

Is Sunrest Lifescie overvalued or undervalued?

2025-09-25 08:03:21

As of 24 September 2025, the valuation grade for Sunrest Lifescie has moved from attractive to fair. The company appears to be fairly valued based on its current metrics, with a PE ratio of 9.44, an EV to EBITDA of 8.26, and a PEG ratio of 0.01. These ratios suggest that while the company is not undervalued, it also does not exhibit the characteristics of being overvalued. In comparison to its peers, Sunrest Lifescie's valuation is significantly lower than that of Elitecon International, which has a PE ratio of 493.62, and Lloyds Enterprises, with a PE of 29.64. However, it is more favorable than PTC India, which has a PE of 8.19, indicating that Sunrest is positioned reasonably within its competitive landscape. Notably, the stock has underperformed against the Sensex, with a year-to-date return of -14.56% compared to the Sensex's positive return of 5.97%, reinforcing the notion of a fair valuation amidst ...

Read More

Why is Sunrest Lifescie falling/rising?

2025-09-24 23:43:39

As of 24-Sep, Sunrest Lifescience Ltd is currently priced at 44.00, with no change in price (0.00%, flat). The stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend in its price performance. Despite this, there has been a significant increase in investor participation, with delivery volume rising by 1733.33% against the 5-day average, suggesting heightened interest in the stock. Over the past month, the stock has experienced a decline of 14.48%, while its year-to-date performance shows a drop of 14.56%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Sunrest Lifescience's short-term performance has been relatively better than the benchmark Sensex, which has declined by 1.08% over the past week compared to the ...

Read More

Why is Sunrest Lifescie falling/rising?

2025-09-23 23:52:55

As of 23-Sep, Sunrest Lifescience Ltd is experiencing a decline in its stock price, currently at Rs. 44.00, which reflects a decrease of Rs. 4.2 or 8.71%. The stock has hit a new 52-week low today and has underperformed its sector by 7.13%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 0.68%, and in the last month, it has seen a significant drop of 14.48%. Year-to-date, the stock is down 14.56%, and over the past year, it has fallen by 26.30%. Notably, there has been a rise in investor participation, with delivery volume increasing by 66.67% against the 5-day average, indicating some interest despite the overall decline. In the broader market context, the Sensex has shown a slight decline of 0.28% over the past week, which is less than the stock's performance. While the benchmark has gained 1.20% in the last...

Read More

View All News